Clinical Trial Update: Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of p53 gene therapy in combination with immune checkpoint inhibitors for solid tumors and lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Immune checkpoint inhibitors (immune checkpoint inhibitor)
• p53 gene therapy (p53 gene therapy)

Snippet

Sponsor: MultiVir, Inc. | Conditions: Solid Tumor, Lymphoma | Phase 2 | Status: UNKNOWN